Clinical Trial Update: A Single-dose Study of Intranasal Ketorolac in the Treatment of Pain Secondary to Dental Impaction Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a single-dose intranasal ketorolac for pain following dental impaction surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Impaction

Drugs mentioned

• Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: Egalet Ltd | Conditions: Pain, Dental Impaction | Phase 2 | Status: COMPLETED